-
2-(3-(2,4-Difluorophenyl)-4,5-dihydroisoxazol-5-yl)-1-morpholinoethan-1-one
-
BD009269641309793-47-297%
-
¥8281.01g
-
3-(3-Hydroxybenzyl)-5-methylbenzo[d]oxazol-2(3H)-one
-
BD015608111208448-95-698%
-
¥2310.010mg
-
4-Iodo-6-phenylpyrimidine
-
BD0079566441270-96-698%
-
¥836.050mg
-
6-(Morpholino(4-(trifluoromethyl)phenyl)methyl)benzo[d][1,3]dioxol-5-ol
-
BD00745587289657-30-398%
-
¥1337.05mg
-
2-(Pyridin-2-yl)-4H-benzo[e][1,3]thiazin-4-one
-
BD55928099420-15-297%
-
¥882.050mg
-
6,6'-((3,3'-Dimethoxy-[1,1'-biphenyl]-4,4'-diyl)bis(diazene-2,1-diyl))bis(4-amino-5-hydroxynaphthalene-1,3-disulfonic acid), tetrasodium salt
-
BD1055232610-05-1Dye content 50%
-
¥120.05g
-
MIF-IN-1
-
BD01485387851095-20-098%
-
¥
-
MIF2-IN-1
-
BD015198272917525-79-098%
-
¥
-
MKA031
-
BD023365372951012-00-198%
-
¥
-
MIF-IN-6
-
BD016028762582758-61-898%
-
¥
-
4-(3-Carboxyphenyl)pyridine-2,5-dicarboxylic acid
-
BD0164339229553-70-698%
-
¥
-
MIF-IN-2
-
BD014795742756410-57-698%
-
¥
-
(S)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one phosphate
-
BD00957660823817-58-998%
-
¥13221.0100mg
-
((1aS,8S,8aR,8bS)-6,8a-Dimethoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate
-
BD009502304055-39-498+%
-
¥8876.0250mg
-
(S)-N-((R)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-N-methylpyrrolidine-2-carboxamide hydrochloride
-
BD0111340463236-23-799+%
-
¥
-
MIF-IN-5
-
BD016094952582755-31-398%
-
¥
-
MIF-IN-3
-
BD015086832756410-83-898%
-
¥
-
Imalumab
-
BD016248851430205-07-495%
-
¥
-
MIF-IN-4 hydrochloride
-
BD014791532489514-05-698%
-
¥
-
R110
-
BD014675251985622-33-098%
-
¥